The Hormone Timeline

The transition is usually described as "estrogen declining" — a smooth downhill ramp that implies the tests should show less of everything, gradually. The actual curves are stranger and more interesting: estradiol first becomes erratic and can spike higher than it ever did in your thirties, progesterone fades first, and FSH — the pituitary's shout into the fading ovary — rises years before anything else looks wrong. This page plots the three curves, explains the strange first act, and is blunt about when a lab test helps and when it just adds noise.

Three Hormones, Three Different Fates

The cast, briefly: estradiol is the ovary's dominant estrogen — the one doing the heavy lifting in brain, bone, vessels, and skin that the parent topic catalogs. Progesterone is the post-ovulation hormone: it rises after an egg is released, stabilizes the uterine lining, and drops if no pregnancy follows. FSH — follicle-stimulating hormone — is a pituitary messenger that tells the ovaries to ripen eggs; it is regulated by feedback from ovarian signals, so when the ovary slows, FSH rises like a manager shouting into a quiet office. Each follows a different timeline, and mixing them up is the source of most lab-test confusion.

Estradiol: The Roller Coaster

The textbook picture — estradiol gently declining from the mid-40s — is wrong in an important way. The classic measurements, going back to Sherman and Korenman's careful cycle studies (Journal of Clinical Investigation, 1975), show that perimenopausal cycles often run high estradiol — sometimes above levels seen in younger women — as the ovary responds to rising FSH with big, uneven surges. This is the biological source of the "wired and weepy" pattern, sore breasts, and heavy or close-together periods in early perimenopause. The Melbourne Women's Midlife Health Project, which followed women with repeated hormone sampling across the transition, confirmed the shape: erratically high, then a genuine fall (Burger et al., Human Reproduction Update, 2007). The end state is what people picture all along: after the final period, estradiol settles typically below 20–30 pg/mL and often under 10 — a decline of roughly 90% from reproductive peaks. Fat tissue keeps producing a weaker estrogen, estrone, which is why body composition shapes the postmenopausal picture.

Progesterone: The First to Leave

Progesterone's curve falls first, because progesterone depends on ovulation and ovulation is the first thing to become unreliable. Starting in the late 30s and 40s, cycles increasingly skip egg release — anovulatory cycles — which means the luteal-phase progesterone surge never happens. The consequences are concrete: without progesterone's stabilizing effect on the uterine lining, cycles shorten, then lengthen unpredictably, and bleeding becomes heavier in some women — the cycle chaos the staging page uses as its primary criterion. After menopause, progesterone falls to near zero (below 1 ng/mL), which is why combined hormone therapy — estrogen plus a progestogen to protect the uterine lining — is the standard for women with a uterus; the Hormone Therapy topic explains that distinction in full.

FSH: The Pituitary Shouting Louder

FSH is the timeline's early-warning signal. Long before estradiol drops for good, the ovary's feedback signals weaken — particularly inhibin B, which falls first as the follicle pool shrinks — and the pituitary compensates by raising FSH (Burger et al., Human Reproduction Update, 2007). That is why a woman in early transition can have both high FSH and normal-to-high estradiol: the pituitary is shouting because the ovary is answering inconsistently, not because it has gone silent. In late transition FSH is typically above 25 IU/L (the STRAW+10 supportive criterion), and after menopause it stabilizes high — often 50–100 IU/L. The practical lesson: a single FSH draw in midlife tells you the pituitary is working and little else.

What the Timeline Predicts

• 🔥 Vasomotor symptoms track the fall. Hot flashes cluster in the stretch where estradiol drops for good and FSH plateaus high — late transition through the first postmenopausal years, matching the onset-stage logic on the staging page.
• 🦴 Bone loss begins before the final period. The resorption ledger tips as estradiol comes down, not after — why the Bone Health topic treats late transition as the moment to start paying attention.
• 🌙 Sleep disruption rides the same wave. Night sweats and the hormonal flux itself fragment sleep — the deep dive lives in Sleep, Mood & the Shift.
• 💊 Therapy timing hangs off the curves. The "timing hypothesis" — that hormone therapy's risk profile differs by how close to menopause it starts — is a statement about where you are on this timeline. The Hormone Therapy topic owns that evidence.

When a Lab Test Is Actually Useful

During perimenopause, routine hormone panels mostly add noise: the values bounce with each cycle, and neither FSH nor estradiol can stage you — which is why professional guidance, including the North American Menopause Society's, treats the transition as a clinical diagnosis made on symptoms and cycle history. Labs earn their keep in specific situations instead. Confirming postmenopause in an ambiguous case — FSH in the 50–100 range settles it. A transition before 40: premature ovarian insufficiency is a different diagnosis with a different workup, and it deserves a clinician. Ruling out mimics: thyroid function, prolactin, and — after heavy bleeding — iron and ferritin, because the anemia and thyroid disease that masquerade as menopause symptoms are exactly the ones a symptom checklist cannot distinguish. ⚠️ This is clinician territory: which tests, when, and how to interpret them is a conversation with a qualified professional, not a self-order.

Related Topics